Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinhard Ebner

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
International Journal of Cancer|March 18, 2004
D-PCa-2: a novel transcript highly overexpressed in human prostate and prostate cancerBernd Weigle, Andrea Kiessling, Reinhard Ebner, et al.
The Prostate|March 12, 2005
D-TMPP: a novel androgen-regulated gene preferentially expressed in prostate and prostate cancer that is the first characterized member of an eukaryotic gene familyAndrea Kiessling, Bernd Weigle, Susanne Fuessel, et al.
Biochemical and Biophysical Research Communications|August 18, 2004
D-GPCR: a novel putative G protein-coupled receptor overexpressed in prostate cancer and prostateBernd Weigle, Susanne Fuessel, Reinhard Ebner, et al.
International Journal of Cancer|May 18, 2010
A genomic strategy for the functional validation of colorectal cancer genes identifies potential therapeutic targetsMarian Grade, Amanda B Hummon, Jordi Camps, et al.
Carcinogenesis|October 11, 2011
Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapyEmil Kendziorra, Kerstin Ahlborn, Melanie Spitzner, et al.
International Journal of Cancer|August 13, 2013
STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivoMelanie Spitzner, Birte Roesler, Christian Bielfeld, et al.
Research Square|April 22, 2024
Increased frequency of CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression without inducing homologous recombination deficiencyZoltan Szallasi, Miklos Diossy, Viktoria Tisza, et al.
Ebiomedicine|February 5, 2016
A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American menGyorgy Petrovics, Hua Li, Tanja Stümpel, et al.
NPJ Precision Oncology|September 18, 2024
Frequent CHD1 deletions in prostate cancers of African American men is associated with rapid disease progressionMiklos Diossy, Viktoria Tisza, Hua Li, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
International Journal of Cancer|March 18, 2004
D-PCa-2: a novel transcript highly overexpressed in human prostate and prostate cancerBernd Weigle, Andrea Kiessling, Reinhard Ebner, et al.
The Prostate|March 12, 2005
D-TMPP: a novel androgen-regulated gene preferentially expressed in prostate and prostate cancer that is the first characterized member of an eukaryotic gene familyAndrea Kiessling, Bernd Weigle, Susanne Fuessel, et al.
Biochemical and Biophysical Research Communications|August 18, 2004
D-GPCR: a novel putative G protein-coupled receptor overexpressed in prostate cancer and prostateBernd Weigle, Susanne Fuessel, Reinhard Ebner, et al.
International Journal of Cancer|May 18, 2010
A genomic strategy for the functional validation of colorectal cancer genes identifies potential therapeutic targetsMarian Grade, Amanda B Hummon, Jordi Camps, et al.
Carcinogenesis|October 11, 2011
Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapyEmil Kendziorra, Kerstin Ahlborn, Melanie Spitzner, et al.
International Journal of Cancer|August 13, 2013
STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivoMelanie Spitzner, Birte Roesler, Christian Bielfeld, et al.
Research Square|April 22, 2024
Increased frequency of CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression without inducing homologous recombination deficiencyZoltan Szallasi, Miklos Diossy, Viktoria Tisza, et al.
Ebiomedicine|February 5, 2016
A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American menGyorgy Petrovics, Hua Li, Tanja Stümpel, et al.
NPJ Precision Oncology|September 18, 2024
Frequent CHD1 deletions in prostate cancers of African American men is associated with rapid disease progressionMiklos Diossy, Viktoria Tisza, Hua Li, et al.
Pageof 2